Paediatric Urology, University Hospital La Paz , Madrid , Spain.
Paediatric Nephrologist, University Hospital La Paz , Madrid , Spain.
Front Pediatr. 2013 Dec 4;1:42. doi: 10.3389/fped.2013.00042. eCollection 2013.
Studies evaluating renal transplant (RT) outcome in children who underwent an augmentation cystoplasty (AC) are contradictory and the current knowledge is based on studies with a limited number of patients. The aim of this study is to compare RT outcome between children who underwent AC and those without augmentation.
A total of 20p who underwent an AC prior to the RT (12 with ureter and 8 with intestine) were enrolled in the study and were compared to a control group of 24p without AC, transplanted in the same time period (1991-2011). Data including; age at transplant, allograft source, urological complications, urinary tract infections (UTI) incidence, the presence of VUR, and patient and graft survival were compared between the groups.
Mean age at RT and mean follow-up were 9.7 vs. 7.9 years and 6.9 vs. 7.9 years in the AC group and control group, respectively (NS). The graft originated in living donors for 60% of AC patients and 41.6% of the control RT patients. The rate of UTI were 0.01 UTI/patient/year and 0.004 UTI/patient/year in the augmented group and controls, respectively (p = 0.0001). In the AC group of 14p with UTIs, 10 (71%) had VUR and 5p out of 8 (62.5%) in the control group had VUR. In the AC group, of the 7p with ≥3 UTIs, 3 (43%) were non-compliant with CIC and the incidence of UTIs was not related with the type of AC or if the patient did CIC through a Mitrofanoff conduit or through the urethra. Graft function at the end of study was 92.9 ± 36.85 ml/min/m(2) in the AC group and 88.17 ± 28.2 ml/min/m(2) in the control group (NS). Graft survival at 10 years was also similar 88% in the AC group and 84.8% in controls. In the AC group 3p lost their grafts and 5 in the control group with respective mean follow-up of 10.6 ± 4.3 and 7.1 + 4.7 years.
There are no significant differences in the RT outcome between children transplanted with AC or without. However, recurrent UTIs are more frequent in the former group and these UTIs are related with non-compliance with CIC or the presence of VUR but, even so, UTIs will not lead to impaired graft function in most of the patients.
评估接受膀胱扩大术(AC)的儿童肾移植(RT)结局的研究结果相互矛盾,目前的知识主要基于患者数量有限的研究。本研究旨在比较接受 AC 和未接受 AC 的儿童的 RT 结局。
本研究共纳入 20 名在 RT 前行 AC 的患儿(12 名输尿管,8 名肠),并与同期(1991-2011 年)接受 RT 且未行 AC 的 24 名患儿进行比较。比较两组患儿的年龄、同种异体移植物来源、泌尿系统并发症、尿路感染(UTI)发生率、存在反流情况、患者和移植物存活率。
AC 组患儿 RT 时的平均年龄和中位随访时间分别为 9.7 岁和 6.9 岁,对照组分别为 7.9 岁和 7.9 岁(无统计学差异)。60%的 AC 患儿和 41.6%的对照组患儿的移植物来源于活体供者。AC 组患儿的 UTI 发生率为 0.01 UTI/患者/年,对照组为 0.004 UTI/患者/年(P=0.0001)。在 14 名发生 UTI 的 AC 组患儿中,10 名(71%)存在反流,对照组的 8 名患儿中有 5 名(62.5%)存在反流。在 AC 组中,7 名发生≥3 次 UTI 的患儿中,3 名(43%)未遵守清洁间歇导尿(CIC),且 UTI 发生率与 AC 类型、患儿是否通过 Mitrofanoff 导管或尿道进行 CIC 无关。研究结束时,AC 组患儿的移植物功能为 92.9±36.85ml/min/m2,对照组为 88.17±28.2ml/min/m2(无统计学差异)。AC 组患儿 10 年移植物存活率为 88%,对照组为 84.8%,也无显著差异。AC 组中有 3 名患儿失去移植物,对照组中有 5 名患儿,两组的平均随访时间分别为 10.6±4.3 年和 7.1±4.7 年。
接受 AC 或未接受 AC 的儿童的 RT 结局无显著差异。然而,前者的复发性 UTI 更为常见,这些 UTI 与不遵守 CIC 或存在反流有关,但即便如此,UTI 也不会导致大多数患者的移植物功能受损。